Live Breaking News & Updates on Division of cancer medicine

Stay informed with the latest breaking news from Division of cancer medicine on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Division of cancer medicine and stay connected to the pulse of your community

Early Responses With CTX130 Renew Hope for Anti-CD70 CAR T-Cell Therapy in Advanced RCC

Early Responses With CTX130 Renew Hope for Anti-CD70 CAR T-Cell Therapy in Advanced RCC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United-states , Texas , Houston , Samera-srour , Division-of-cancer-medicine , Department-of-stem-cell-transplantation , University-of-texas-md-anderson-cancer-center , Stem-cell-transplantation , Cellular-therapy , Cancer-medicine , Cancer-center

APCCC 2024: How Do Non-DDR Genomic Alterations Influence Management of Patients with Advanced Prostate Cancer?

APCCC 2024: How Do Non-DDR Genomic Alterations Influence Management of Patients with Advanced Prostate Cancer?
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

Lugano , Ticino , Switzerland , Texas , United-states , Houston , Toronto , Ontario , Canada , Twitter , Department-of-genitourinary-medical-oncology

Dr Srour on the Ongoing Investigation of CAR T-Cell Therapy in Advanced RCC

Samer A. Srour, MB ChB, MS, discusses the investigation of the allogeneic CAR T-cell therapy CTX131 in advanced clear cell renal cell carcinoma.

Texas , United-states , Samera-srour , Division-of-cancer-medicine , Department-of-stem-cell-transplantation , University-of-texas-md-anderson-cancer-center , Stem-cell-transplantation , Cellular-therapy , Cancer-medicine , Cancer-center , He-university-of-texas-md-anderson-cancer-center

Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO

Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Chicago , Illinois , United-states , United-kingdom , London , City-of , Houston , Texas , American , Susana-noonan , Elias-jabbour , Julia-wilson

OBX-115 With Acetazolamide Induces Safe and Durable Antitumor Responses in Advanced Melanoma

OBX-115 was well tolerated and produced durable antitumor responses in patients with immune checkpoint inhibitor (ICI)-resistant advanced melanoma.

Houston , Texas , United-states , San-diego , California , Lifileucel-amtagvi , Rodaben-amaria , Department-of-melanoma-medical-oncology , University-of-texas-md-anderson-cancer-center , Division-of-cancer-medicine , Melanoma-medical-oncology , Cancer-medicine

Vepdegestrant Shows Potential in ESR1-Mutant ER+/HER2– Breast Cancer

Debu Tripathy, MD, highlights the potential role and significance of vepdegestrant in pretreated ER-positive/HER2-negative breast cancer.

Orrs , Texas , United-states , Houston , University-of-texas-md-anderson-cancer-center , Division-of-cancer-medicine , Department-of-breast-medical-oncology , Arvinas-inc , Pfizer , Debu-tripathy , Antonio-breast-cancer-symposium

Dr Tannir on Unmet Needs in the Treatment of Rare Kidney Tumors

Nizar M. Tannir, MD, FACP, discusses unmet needs for patients with rare kidney tumors and how these needs may be addressed in the future.

Texas , United-states , Horne-jr , Nizarm-tannir , Department-of-genitourinary-medical-oncology , University-of-texas-md-anderson-cancer-center , Professor-for-cancer-research , Division-of-cancer-medicine , Ransom-horne , Cancer-research , Genitourinary-medical-oncology

Dr Lee on the Rationale for Investigating Linvoseltamab in R/R Multiple Myeloma

Hans Lee, MD, discusses the rationale for the phase 1/2 LINKER-MM1 trial of linvoseltamab in patients with relapsed/refractory multiple myeloma.

Texas , United-states , Hans-lee , Department-of-lymphoma-myeloma , University-of-texas-md-anderson-cancer-center , Division-of-cancer-medicine , Myeloma-clinical-research , Multiple-myeloma-clinical-research , Cancer-medicine , Cancer-center , D , Linker-mm1-trial-

Dr Srour on the Safety and Efficacy of the Allogeneic CAR T-Cell Therapy CTX130 in Advanced ccRCC

Samer A. Srour, MB ChB, MS, discusses efficacy and safety data for the allogeneic CAR T-cell therapy CTX130 in advanced clear cell renal cell carcinoma.

Texas , United-states , Samera-srour , University-of-texas-md-anderson-cancer-center , Department-of-stem-cell-transplantation , Division-of-cancer-medicine , Stem-cell-transplantation , Cancer-medicine , Cancer-center , B-chb , S

Dr Overman on Nonoperative Cancer Management in GI Malignancies

Michael J. Overman, MD, discusses the rationale for utilizing a nonoperative management approach over traditional surgery in gastrointestinal cancers.

Texas , United-states , Michaelj-overman , Division-of-cancer-medicine , Department-of-gastrointestinal-medical-oncology , Md-anderson-cancer-network , University-of-texas-md-anderson-cancer-center , Gastrointestinal-medical-oncology , Cancer-medicine , Executive-committee , Medical-staff